Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramDirectorCIK 0001856094
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Borgeson BlakeDirector |  RXRXRECURSION PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $155K 40.0K sh | Nov 4, 2026 traded Nov 3, 2026 | |
Borgeson BlakeDirector |
| RXRXRECURSION PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan |
| SELL |
| $110K 30.0K sh |
| Jun 4, 2026 traded Jun 2, 2026 |
| 9 | Borgeson BlakeDirector | RXRXRECURSION PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $106K 30.0K sh | May 7, 2026 traded May 5, 2026 |
| 9 | Borgeson BlakeDirector | RXRXRECURSION PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $93K 30.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 17 | Borgeson BlakeDirector | RXRXRECURSION PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $959K 220.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 16 | Borgeson BlakeDirector | RXRXRECURSION PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $961K 220.0K sh | Dec 4, 2025 traded Dec 2, 2025 |